A detailed history of Lindbrook Capital, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 105 shares of MEDP stock, worth $36,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105
Previous 126 16.67%
Holding current value
$36,590
Previous $51,000 31.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$320.58 - $457.29 $6,732 - $9,603
-21 Reduced 16.67%
105 $35,000
Q2 2024

Jul 31, 2024

BUY
$372.0 - $424.34 $7,812 - $8,911
21 Added 20.0%
126 $51,000
Q4 2023

Jan 31, 2024

BUY
$227.52 - $312.68 $1,365 - $1,876
6 Added 6.06%
105 $32,000
Q3 2023

Oct 25, 2023

BUY
$233.98 - $281.67 $935 - $1,126
4 Added 4.21%
99 $23,000
Q2 2023

Jul 28, 2023

BUY
$187.26 - $240.17 $936 - $1,200
5 Added 5.56%
95 $22,000
Q1 2023

Apr 26, 2023

SELL
$174.31 - $239.52 $3,137 - $4,311
-18 Reduced 16.67%
90 $16,000
Q4 2022

Jan 24, 2023

SELL
$153.06 - $226.57 $1,071 - $1,585
-7 Reduced 6.09%
108 $0
Q3 2022

Nov 10, 2022

BUY
$145.13 - $182.49 $435 - $547
3 Added 2.68%
115 $18,000
Q2 2022

Aug 01, 2022

SELL
$130.2 - $168.03 $14,191 - $18,315
-109 Reduced 49.32%
112 $17,000
Q1 2022

Apr 21, 2022

SELL
$138.87 - $214.31 $44,993 - $69,436
-324 Reduced 59.45%
221 $36,000
Q4 2021

Jan 18, 2022

BUY
$182.74 - $227.9 $99,593 - $124,205
545 New
545 $119,000
Q2 2021

Jul 27, 2021

SELL
$158.62 - $194.3 $1,903 - $2,331
-12 Closed
0 $0
Q1 2021

Apr 28, 2021

BUY
$132.02 - $168.26 $1,584 - $2,019
12 New
12 $2,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.